Access Statistics for Matthew J. Higgins

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Country‑Specific View of Tariffs 0 3 13 13 2 13 22 22
Accounting for Price Endogeneity in Airline Itinerary Choice Models: An Application to Continental U.S. Markets 0 0 0 46 2 8 11 95
Assets with "Warts": How Reliable is the Market for Technology? 0 0 0 8 0 2 3 40
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 16 1 7 8 84
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-Level Data 0 0 0 37 0 8 12 268
Blockbusters, Sequels and the Nature of Innovation 0 1 14 14 0 10 33 33
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology 0 0 0 34 1 8 9 230
Corporate Venture Capital as a Real Option in the Markets for Technology 0 0 0 71 1 6 8 109
Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks 0 0 2 18 2 6 15 34
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach 0 0 0 29 1 7 11 87
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 61 4 9 12 435
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 47 0 5 14 375
Federal, State, and Local Governments:Evaluating their Separate Roles in US Growth 0 0 0 12 3 7 9 151
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 1 4 2 8 18 52
Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation 0 0 1 41 0 10 24 118
Growth and Convergence across the U.S: Evidence from County-Level Data 0 0 1 255 5 23 27 787
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 204 2 12 24 641
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 7 4 13 14 111
Growth and Convergence across the US: Evidence from County-Level Data 0 0 2 15 0 7 15 185
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 2 0 7 13 32
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 2 2 4 7 103
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 209 0 5 7 1,135
Heterogeneous Convergence 0 0 1 39 2 13 15 348
Heterogeneous Convergence 0 0 0 14 4 17 19 111
Heterogeneous Convergence 0 0 0 15 4 15 18 111
Heterogeneous Convergence 0 0 0 57 2 8 12 216
Heterogeneous convergence 0 0 0 2 0 7 13 41
Intra-alliance performance, control rights, and today's split of tomorrow's value 0 0 0 85 0 9 10 235
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 11 0 2 10 128
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 1 426 1 4 18 3,825
Market Size and Research: Evidence from the Pharmaceutical Industry 0 0 0 17 1 4 6 59
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms 1 1 1 43 3 9 9 70
Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data 0 0 0 1 0 2 7 17
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry 0 0 0 57 0 5 14 281
Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak 0 0 0 2 1 7 9 25
Robust Correlates of County-Level Growth in the U.S 0 0 1 40 0 8 16 186
Robust correlates of county-level growth in the United States 0 0 0 0 0 3 6 18
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 30 0 4 11 135
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data (revised version) 0 0 1 36 1 4 6 132
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 1 0 8 10 29
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 151 4 11 15 544
Sigma-Convergence Versus Beta-Convergence: Evidence from U.S. County-Level Data 0 0 0 522 0 3 5 1,668
Stronger IPR, Better Inclusion? Impact Of WTO Accession On Female AI Inventors in China 0 0 2 14 1 4 11 45
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 56 0 5 8 162
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 46 0 9 12 122
The Effect of Contractual Complexity on Technology Sourcing Agreements 0 0 0 40 1 3 4 263
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry 0 0 0 120 1 5 8 398
The Role of Assets In Place: Loss of Market Exclusivity and Investment 0 0 0 11 2 11 14 49
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 0 14 1 4 7 56
Why Investment‑Led Growth Lowers Chinese Living Standards 0 0 2 17 1 8 19 30
Will Peak Demand Roil Global Oil Markets? 0 0 3 3 3 6 9 9
Total Working Papers 1 5 46 3,015 65 383 637 14,440


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for price endogeneity in airline itinerary choice models: An application to Continental U.S. markets 0 0 3 9 4 7 15 86
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 6 1 11 17 70
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology 0 0 0 24 3 13 21 175
Corporate venture capital as a real option in the markets for technology 0 0 0 6 1 8 18 60
Evaluating the effects of Small Business Administration lending on growth 0 1 5 15 4 11 22 85
Federal, State, and Local Governments: Evaluating Their Separate Roles in US Growth 0 0 1 2 2 10 17 41
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 32 0 5 13 194
Generic competition and the incentives for early-stage pharmaceutical innovation 0 1 4 7 1 7 19 33
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 2 154 1 9 22 432
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 4 3 9 12 40
Heterogeneous Convergence 0 0 0 3 3 10 13 43
Heterogeneous convergence 0 0 0 40 0 10 14 152
How Reliable Is the Market for Technology? 0 0 0 14 0 1 6 77
Modeling competition among airline itineraries 0 1 2 13 3 8 14 66
Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data 0 0 0 0 1 7 7 7
Productivity and the role of complementary assets in firms' demand for technology innovations 0 0 0 23 2 9 11 120
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry 0 0 0 11 1 4 5 79
Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak 0 0 0 0 1 5 13 16
Robust Correlates of County-Level Growth in the U.S 0 0 0 0 0 6 11 60
Robust correlates of county-level growth in the United States 0 0 0 11 0 2 5 55
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 293 1 3 10 1,186
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 4 11 3 12 22 57
Sigma Convergence versus Beta Convergence: Evidence from U.S. County‐Level Data 0 0 1 10 1 3 11 49
Strategic Alliances: Trading Ownership for Capabilities 0 0 0 8 0 4 10 50
The allocation of control rights in pharmaceutical alliances 0 0 0 60 0 0 2 167
The balance of payments crisis in the euro area periphery 0 1 2 180 1 8 27 717
The impact of advance purchase deadlines on airline consumers’ search and purchase behaviors 0 0 1 8 1 4 8 63
The outsourcing of R&D through acquisitions in the pharmaceutical industry 0 1 7 374 1 7 30 1,045
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 1 4 1 3 8 25
Total Journal Articles 0 5 33 1,322 40 196 403 5,250


Statistics updated 2026-03-04